Stanley Druckenmiller's TEVA Position Overview
Stanley Druckenmiller (via Duquesne Family Office LLC) currently holds 16.59 M shares of Teva Pharmaceutical Industries Limited (TEVA) worth $335.2 M, representing 8.25% of the portfolio. First purchased in 2013-Q4, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Stanley Druckenmiller has maintained a strategic position in TEVA, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 7.57 M shares. Largest reduction occurred in Q3 2014, reducing 1.24 M shares.
Analysis based on 13F filings available since 2013 Q2
Stanley Druckenmiller's Teva Pharmaceutical Industries Limited (TEVA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Teva Pharmaceutical Industries Limited (TEVA) Trades by Stanley Druckenmiller
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2013 | +1.24 M | New Buy | 1.24 M | $40.08 |
| Q3 2014 | -1.24 M | Sold Out | 0 | $0.00 |
| Q1 2015 | +790,500 | New Buy | 790,500 | $62.30 |
| Q2 2015 | -790,500 | Sold Out | 0 | $0.00 |
| Q3 2024 | +1.43 M | New Buy | 1.43 M | $18.02 |
| Q4 2024 | +7.57 M | Add 530.09% | 9 M | $22.04 |
| Q1 2025 | +5.88 M | Add 65.38% | 14.88 M | $15.37 |
| Q2 2025 | +1.09 M | Add 7.32% | 15.97 M | $16.76 |
| Q3 2025 | +625,000 | Add 3.91% | 16.59 M | $20.20 |
Stanley Druckenmiller's Teva Pharmaceutical Industries Limited Investment FAQs
Stanley Druckenmiller first purchased Teva Pharmaceutical Industries Limited (TEVA) in Q4 2013, acquiring 1,241,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Stanley Druckenmiller has held Teva Pharmaceutical Industries Limited (TEVA) for 11 quarters since Q4 2013.
Stanley Druckenmiller's largest addition to Teva Pharmaceutical Industries Limited (TEVA) was in Q4 2024, adding 8,997,400 shares worth $198.3 M.
According to the latest 13F filing for Q3 2025, Stanley Druckenmiller's firm, Duquesne Family Office LLC, owns 16,593,935 shares of Teva Pharmaceutical Industries Limited (TEVA), valued at approximately $335.2 M.
As of the Q3 2025 filing, Teva Pharmaceutical Industries Limited (TEVA) represents approximately 8.25% of Stanley Druckenmiller's publicly disclosed stock portfolio, making it one of their key holdings.
Stanley Druckenmiller's peak holding in Teva Pharmaceutical Industries Limited (TEVA) was 16,593,935 shares, as reported at the end of Q3 2025.